NCT00080899 2015-03-06
Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
5 trialsNCT00053326 2013-10-08
Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00077402 2013-05-15
Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00026091 2013-03-25
Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00009971 2013-02-11
Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed